Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MDA-MB-134-VI
HR+
Luminal
FTase Inhibitor I
Ftase
MAPK
10998.154
uM
inf
inf
0.7776 0.7776 0.0000 0.1253
-0.1381
0.7412
HCC1428
HR+
Luminal
FTase Inhibitor I
Ftase
MAPK
10693.154
uM
inf
inf
0.9040 0.9040 0.0000 0.0850
-0.1383
0.8696
MDA-MB-415
HR+
Luminal
Methotrexate
DHFR
Metabolism
7510.084
uM
inf
inf
0.8517 0.8517 0.0000 0.0588
0.1386
0.8702
HCC1419
HER2amp
Luminal
PS-1145
IKK
NFKB
7437.065
uM
inf
inf
1.0125 1.0125 0.0000 0.0500
0.1389
0.5183
MDA-MB-175-VII
HR+
Luminal
Ro 32-0432
PKC
PKC
10642.142
uM
inf
inf
0.8827 0.8827 0.0000 0.0460
0.1393
0.5006
MDA-MB-415
HR+
Luminal
2-deoxyglucose
12959.177
uM
inf
inf
0.3997 0.3997 0.0000 0.1758
0.1401
0.5538
ZR-75-1
HR+
Luminal
GM6001
MMP
MMP
7553.096
uM
inf
inf
0.8456 0.8456 0.0000 0.1005
-0.1404
1.1407
SUM185PE
TNBC
Luminal
Dichloroacetate
PDK
PDK
13140.176
uM
inf
inf
0.8118 0.8118 0.0000 0.0909
-0.1414
0.6663
MDA-MB-453
TNBC
Luminal
Ribavirin
15398.211
uM
inf
inf
0.8982 0.8982 0.0000 0.0145
0.1417
1.0628
MCF 10F
NM
-
(Z)-4-Hydroxytamoxifen
ESR1
9566.132
uM
inf
inf
0.8030 0.8030 0.0000 0.1021
0.1442
2.4013
MDA-MB-453
TNBC
Luminal
Purvalanol A
CDK1
CDK
7518.067
uM
inf
inf
0.8749 0.8749 0.0000 0.2698
-0.1447
0.7666
MCF 10F
NM
-
Gefitinib
EGFR
ErbB
9566.132
uM
inf
inf
0.7541 0.7541 0.0000 0.0697
0.1447
2.4013
SUM159PT
TNBC
Basal B
Nelfinavir
13054.174
uM
inf
inf
0.9613 0.9613 0.0000 0.0251
0.1450
3.1161
MDA-MB-175-VII
HR+
Luminal
FTase Inhibitor I
Ftase
MAPK
12126.154
uM
inf
inf
0.6563 0.6563 0.0000 0.2735
-0.1456
0.6012
SUM159PT
TNBC
Basal B
Cetuximab
EGFR
ErbB
7918.018
uM
inf
inf
0.9278 0.9278 0.0000 0.0321
0.1456
3.0213
MCF7
HR+
Luminal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7492.095
uM
inf
inf
0.7935 0.7935 0.0000 0.2394
-0.1467
1.0194
CAMA-1
HR+
Luminal
Nilotinib
ABL
nRTK
10755.145
uM
inf
inf
0.9059 0.9059 0.0000 0.0960
0.1467
0.7688
SK-BR-3
HER2amp
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7527.085
uM
inf
inf
0.6561 0.6561 0.0000 0.0637
0.1476
1.9392
MDA-MB-415
HR+
Luminal
PS-1145
IKK
NFKB
7512.065
uM
inf
inf
0.9567 0.9567 0.0000 0.0006
0.1478
0.9176
UACC-812
HER2amp
Luminal
Baicalein
Lipoxygenase
Metabolism
10420.072
uM
inf
inf
0.5919 0.5919 0.0000 0.1697
0.1494
0.5007
HCC1569
HER2amp
Basal A
PD 98059
MEK
MAPK
10872.152
uM
inf
inf
0.7580 0.7580 0.0000 0.1442
0.1498
1.5916
MDA-MB-415
HR+
Luminal
L-779450
BRAF
MAPK
10938.149
uM
inf
inf
0.7318 0.7318 0.0000 0.2167
0.1498
1.0006
MDA-MB-415
HR+
Luminal
NU6102
CDK1/2
CDK
10938.147
uM
inf
inf
-0.2305 -0.2305 0.0000 0.3696
0.1504
0.9050
MDA-MB-453
TNBC
Luminal
PS-1145
IKK
NFKB
7518.065
uM
inf
inf
0.9324 0.9324 0.0000 -0.0310
-0.1509
1.3677
SUM185PE
TNBC
Luminal
Methotrexate
DHFR
Metabolism
7532.084
uM
inf
inf
0.8047 0.8047 0.0000 0.0855
0.1512
0.7770